SNX-III ADMINISTERED TO PATIENTS WITH CHRONIC NON-MALIGNANT PAIN

SNX-III 用于慢性非恶性疼痛患者

• 批准号: 6117968
• 负责人: MARK S WALLACE
• 金额: $ 1.46万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6117968
• 关键词: analgesics; chronic disease /disorder; clinical research; dosage; drug administration routes; drug adverse effect; endogenous opioid; human subject; human therapy evaluation; pain

Assess the safety and efficacy of increasing doses of SNX-111 administered intrathecally to patients with chronic, non-malignant pain.

评估对患有慢性非恶性疼痛的患者鞘内注射增加剂量的 SNX-111 的安全性和有效性。